Runben Biotechnology Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	9,650	9,447	7,356	-	-	-
Market Cap Growth	-2.77%	28.44%	-	-	-	-
Enterprise Value	8,520	9,054	6,808	-	-	-
Last Close Price	23.85	23.05	17.66	-	-	-
PE Ratio	31.42	31.47	32.54	-	-	-
Forward PE	28.62	26.27	26.80	-	-	-
PS Ratio	6.36	7.17	7.12	-	-	-
PB Ratio	4.44	4.54	3.83	-	-	-
P/TBV Ratio	4.63	4.66	3.87	-	-	-
P/FCF Ratio	49.57	51.62	30.79	-	-	-
P/OCF Ratio	32.41	36.73	29.13	-	-	-
EV/Sales Ratio	5.61	6.87	6.59	-	-	-
EV/EBITDA Ratio	24.16	27.62	25.94	-	-	-
EV/EBIT Ratio	25.66	29.38	28.06	-	-	-
EV/FCF Ratio	43.77	49.47	28.50	-	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.01	0.02	-
Debt / EBITDA Ratio	0.00	0.01	0.02	0.04	0.07	-
Debt / FCF Ratio	0.01	0.02	0.02	0.06	-	-
Asset Turnover	0.67	0.62	0.73	1.16	1.26	2.01
Inventory Turnover	4.93	5.23	4.64	4.93	5.40	5.64
Quick Ratio	9.02	10.58	16.93	3.97	3.64	3.72
Current Ratio	12.51	11.63	18.04	5.28	4.56	5.85
Return on Equity (ROE)	14.49%	15.00%	17.10%	24.93%	29.72%	48.88%
Return on Assets (ROA)	9.17%	9.09%	10.66%	15.06%	17.69%	30.29%
Return on Invested Capital (ROIC)	31.14%	54.09%	60.54%	45.44%	45.56%	67.89%
Return on Capital Employed (ROCE)	15.20%	14.80%	12.60%	24.30%	22.90%	42.40%
Earnings Yield	3.16%	3.18%	3.07%	-	-	-
FCF Yield	2.02%	1.94%	3.25%	-	-	-
Dividend Yield	1.93%	1.78%	0.96%	-	-	-
Payout Ratio	79.01%	45.32%	-	2.15%	25.65%	-
Buyback Yield / Dilution	0.23%	-14.85%	-3.71%	-1.61%	-9.69%	-499.54%
Total Shareholder Return	2.13%	-13.07%	-2.75%	-1.61%	-9.69%	-499.54%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.